Alvotech (ALVO) Provisions (2020 - 2023)
Alvotech's (ALVO) quarterly Provisions came in at -$3.1 million in Q2 2023, down 164.95% on a YoY basis from $4.7 million in Q2 2022, and down 129.16% quarter-over-quarter from $10.6 million in Q4 2022.
Analysis
Alvotech (ALVO) Provisions (2020 - 2023) Analysis & Trends
Alvotech (ALVO) has reported Provisions for 4 consecutive years, with -$3.1 million the latest figure, recorded in Q2 2023.
- For the quarter ending Q2 2023, Provisions fell 164.95% year-over-year to -$3.1 million; the trailing twelve-month figure through Jun 2023 stood at -$3.1 million (down 164.95% YoY), and the FY2022 full-year result was $10.6 million, up 294.11% from the prior year.
- Provisions eased to -$3.1 million in Q2 2023 per ALVO's latest filing, from $10.6 million in the prior quarter.
- Across five years, Provisions topped out at $10.6 million in Q4 2022 and bottomed at -$3.1 million in Q2 2023.
- Historically, Provisions has averaged $3.6 million across 4 years, with a median of $3.2 million in 2020.
- The sharpest annual moves came in 2022 and 2023: Provisions soared 294.11% in 2022, then slumped 164.95% in 2023.
- Over 4 years, Provisions stood at $3.2 million in 2020, then retreated by 16.61% to $2.7 million in 2021, then jumped by 294.11% to $10.6 million in 2022, then plunged by 129.16% to -$3.1 million in 2023.
- According to Business Quant data, Provisions over the past three periods registered -$3.1 million, $10.6 million, and $4.7 million for Q2 2023, Q4 2022, and Q2 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Provisions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.74 Bn | 39.08 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.12 Bn | 18.23 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 990.94 Mn | 700.81 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 412.47 Mn | 371.22 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.64 Mn | 178.64 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -3.08 Mn |
| Dec 31, 2022 | 10.57 Mn |
| Jun 30, 2022 | 4.74 Mn |
| Dec 31, 2021 | 2.68 Mn |
| Dec 31, 2020 | 3.22 Mn |